Across 2,783 participants, GLP-1RAs were associated with: - Higher rates of MASH resolution without worsening fibrosis - Reduced liver fat and improved ALT, AST, and GGT levels - Significant decreases in body weight, BMI, waist circumference, HbA1c, and triglycerides While gastrointestinal side effects (nausea, vomiting, diarrhea) were more common, the overall benefit profile was substantial
At SDBotox San Diego , we currently offer: Semaglutide (commonly known as Wegovy or Ozempic) one of the most popular and widely studied GLP-1 medications, proven to help patients lose a significant percentage of body weight
Semaglutide patients often benefit from B12 supplementation, especially if they reduce red meat consumption
Metabolic stress in autophagy and cell death pathways
D., Wu J., Lu J., Nikonov S., et al